BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15059166)

  • 21. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
    Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
    JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of features indicating progression in atypical squamous cells with undetermined significance: human papillomavirus typing and DNA ploidy analysis from liquid-based cytologic samples.
    Bollmann R; Méhes G; Torka R; Speich N; Schmitt C; Bollmann M
    Cancer; 2003 Apr; 99(2):113-7. PubMed ID: 12704691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Significance of Atypical Squamous Cells of Undetermined Significance among Patients Undergoing Cervical Conization.
    Nishimura M; Miyatake T; Nakashima A; Miyoshi A; Mimura M; Nagamatsu M; Ogita K; Yokoi T
    Asian Pac J Cancer Prev; 2015; 16(18):8145-7. PubMed ID: 26745052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical precancerous lesions.
    Gage JC; Schiffman M; Solomon D; Wheeler CM; Castle PE
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1668-74. PubMed ID: 20615884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities.
    Gage JC; Schiffman M; Solomon D; Wheeler CM; Gravitt PE; Castle PE; Wentzensen N
    Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1095-101. PubMed ID: 23603204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-risk HPV DNA detection by Hybrid Capture II. An adjunctive test for mildly abnormal cytologic smears in women > or = 50 years of age.
    Lin CT; Tseng CJ; Lai CH; Hsueh S; Huang HJ; Law KS
    J Reprod Med; 2000 Apr; 45(4):345-50. PubMed ID: 10804494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus type-specific 18-month risk of high-grade cervical intraepithelial neoplasia in women with a normal or borderline/mildly dyskaryotic smear.
    Berkhof J; Bulkmans NW; Bleeker MC; Bulk S; Snijders PJ; Voorhorst FJ; Meijer CJ
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1268-73. PubMed ID: 16835322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
    BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of variable methods for HPV testing].
    Cheng JY; Bian ML; Ma L; Cong X; Chen Y; Liu J
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):589-94. PubMed ID: 24199924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Papillomavirus detection: demographic and behavioral characteristics influencing the identification of cervical disease.
    Adam E; Berkova Z; Daxnerova Z; Icenogle J; Reeves WC; Kaufman RH
    Am J Obstet Gynecol; 2000 Feb; 182(2):257-64. PubMed ID: 10694321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is human papillomavirus testing an effective triage method for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia?
    Adam E; Kaufman RH; Berkova Z; Icenogle J; Reeves WC
    Am J Obstet Gynecol; 1998 Jun; 178(6):1235-44. PubMed ID: 9662307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology.
    McIntyre-Seltman K; Castle PE; Guido R; Schiffman M; Wheeler CM;
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1165-70. PubMed ID: 15894667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia.
    Mariano VS; Lorenzi AT; Scapulatempo-Neto C; Stein MD; Resende JC; Antoniazzi M; Villa LL; Levi JE; Longatto-Filho A; Fregnani JH
    PLoS One; 2016; 11(10):e0164892. PubMed ID: 27764154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.
    Cox JT; Lorincz AT; Schiffman MH; Sherman ME; Cullen A; Kurman RJ
    Am J Obstet Gynecol; 1995 Mar; 172(3):946-54. PubMed ID: 7892889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
    Recio FO; Sahai Srivastava BI; Wong C; Hempling RE; Eltabbakh GH; Piver MS
    Eur J Gynaecol Oncol; 1998; 19(3):203-8. PubMed ID: 9641214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of cervical intraepithelial neoplasia in women with atypical squamous or glandular cells of undetermined significance cytology: a prospective study.
    Wensveen C; Kagie M; Veldhuizen R; De Groot C; Denny L; Zwinderman K; Trimbos B
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):883-9. PubMed ID: 12911453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
    Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
    J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.
    Ibáñez R; Moreno-Crespi J; Sardà M; Autonell J; Fibla M; Gutiérrez C; Lloveras B; Alejo M; Català I; Alameda F; Casas M; Bosch FX; de Sanjosé S
    BMC Infect Dis; 2012 Jan; 12():25. PubMed ID: 22280073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data.
    Uijterwaal MH; Polman NJ; Witte BI; van Kemenade FJ; Rijkaart D; Berkhof J; Balfoort-van der Meij GA; Ridder R; Snijders PJ; Meijer CJ
    Int J Cancer; 2015 May; 136(10):2361-8. PubMed ID: 25345358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.